National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 6) (No. PB 73 of 2013) (Cth)

PB 73 of 2013

National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 6)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health , delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated                  14         October 2013

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 6).

(2)   This Determination may also be cited as PB 73 of 2013.

1. Commencement

This Determination commences on 1 November 2013.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Tiagabine

Omit

Tiaprofenic acid